Xeltis' FIH Study of aXess Vascular Graft for Hemodialysis Is Presented
May 5, 2023—Xeltis recently announced the presentation of 6-month data from its first-in-human (FIH) trial of the company’s aXess vascular
Source: evtoday.com
Matteo Tozzi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Matteo Tozzi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Matteo Tozzi Today - Breaking & Trending Today
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress aXess graft demonstrated excellent patency
Source: finanznachrichten.de
Xeltis' Axess Restorative Hemodialysis Access Graft Evaluated in Early Data From FIH Trial
April 27, 2022—Xeltis announced preliminary results from a clinical trial of the company’s Axess restorative hemodialysis access graft. Ax
Source: evtoday.com